Inhibitory action of a new proton pump inhibitor, trifluoromethyl ketone derivative, against the motility of clarithromycin-susceptible and-resistant Helicobacter pylori

被引:23
|
作者
Spengler, G
Molnar, A
Klausz, G
Mandi, Y
Kawase, M [1 ]
Motohashi, N
Molnar, J
机构
[1] Univ Szeged, Fac Med, Albert Szent Gyorgyi Med Ctr, Dept Med Microbiol & Immunobiol, Szeged, Hungary
[2] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan
[3] Meiji Pharmaceut Univ, Tokyo, Japan
关键词
motility; Helicobacter pylori; clarithromycin-resistant; trifluoromethyl ketone; proton pump;
D O I
10.1016/j.ijantimicag.2003.11.010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We previously reported that a trifluoromethyl ketone derivative, 1-(2-benzoxazolyl)-3,3,3-trifluoro-2-propanone (TF18), exhibited the potent antibacterial activity against Helicobacter pylori, but had no urease activity. In order to clarify the mechanism of anti-H. pylori action of TF18, we evaluated the growth and motility of TF18 on clarithromycin-susceptible H. pylori (CSHP) and -resistant H. pylori (CRHP). An effective proton pump inhibitor (TF18) had remarkable dose-dependent antibacterial activity and was able to inhibit the flagellar motor of both CSHP and CRHP isolates. The antimotility effect of TF18 was more pronounced at subinhibitory concentration in CRHP than in CSHP. The swimming (the forward motion) was more sensitive to the inhibition than the tumbling. Based on the results, it is supposed that TF18 works as an uncoupler similar to the 'clutch' in a biological motor, in which counterclockwise rotation is more sensitive to the effect of TF18 than the clockwise rotation. (C) 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:631 / 633
页数:3
相关论文
共 11 条
  • [1] Inhibitory action of a novel proton pump inhibitor, rabeprazole, and its thioether derivative against the growth and motility of clarithromycin-resistant Helicobacter pylori
    Ohara, T
    Goshi, S
    Taneike, I
    Tamura, Y
    Zhang, HM
    Yamamoto, T
    HELICOBACTER, 2001, 6 (02) : 125 - 129
  • [2] A novel action of the proton pump inhibitor rabeprazole and its thioether derivative against the motility of Helicobacter pylori
    Tsutsui, N
    Taneike, I
    Ohara, T
    Goshi, S
    Kojio, S
    Iwakura, N
    Matsumaru, H
    Wakisaka-Saito, N
    Zhang, HM
    Yamamoto, T
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) : 3069 - 3073
  • [3] The bactericidal activity of clarithromycin versus ampicillin alone and in combination with omeprazole and/or bismuth against clarithromycin-susceptible and. Clarithromycin-resistant strains of Helicobacter pylori
    Coudron, PE
    Stratton, CW
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 32 (01) : 39 - 44
  • [4] Inhibitory action of YJA2-379, a new proton pump inhibitor of Helicobacter pylori growth and urease
    Woo, TW
    Chang, MS
    Chung, YK
    Kim, KB
    Sohn, SK
    Kim, SG
    Choi, WS
    ARCHIVES OF PHARMACAL RESEARCH, 1998, 21 (01) : 6 - 11
  • [5] POTENT INHIBITORY-ACTION OF THE GASTRIC PROTON PUMP INHIBITOR LANSOPRAZOLE AGAINST UREASE ACTIVITY OF HELICOBACTER-PYLORI - UNIQUE ACTION SELECTIVE FOR HELICOBACTER-PYLORI CELLS
    NAGATA, K
    SATOH, H
    IWAHI, T
    SHIMOYAMA, T
    TAMURA, T
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (04) : 769 - 774
  • [6] Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori: A multicenter, prospective, randomized trial
    Sue, Soichiro
    Ogushi, Marina
    Arima, Isao
    Kuwashima, Hirofumi
    Nakao, Satoshi
    Naito, Makoto
    Komatsu, Kazuo
    Kaneko, Hiroaki
    Tamura, Toshihide
    Sasaki, Tomohiko
    Kondo, Masaaki
    Shibata, Wataru
    Maeda, Shin
    HELICOBACTER, 2018, 23 (02)
  • [7] Inhibitory action of YJA20379, a new proton pump inhibitor onHelicobacter pylori growth and urease
    Tae-Wook Woo
    Man-Sik Chang
    Young-Kuk Chung
    Kyu-Bong Kim
    Sang-Kwon Sohn
    Sung-Gyu Kim
    Wahn-Soo Choi
    Archives of Pharmacal Research, 1998, 21 : 6 - 11
  • [8] Effect of triple therapy with new proton pump inhibitor rabeprazole, amoxicillin and low or high dose of clarithromycin for Helicobacter pylori infection
    Kihira, K
    Sugano, K
    Kimura, K
    Satoh, K
    GUT, 1999, 45 : A117 - A117
  • [9] Effect of triple therapy with new proton pump inhibitor rabeprazole, amoxicillin and low or high dose of clarithromycin for Helicobacter pylori infection
    Kihira, K
    Satoh, K
    Fukazawa, K
    Kawakami, S
    Sugano, K
    GASTROENTEROLOGY, 1999, 116 (04) : A213 - A213
  • [10] Effect of amoxicillin, clarithromycin, and rabeprazole, a new proton pump inhibitor, in eradication therapy for relapsing peptic ulcer diseases with Helicobacter pylori infection
    Hizawa, K
    Nakahara, T
    Yano, Y
    Inuzuka, S
    Akagi, K
    Matsumoto, T
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2000, 31 (04) : 338 - 339